Trials / Completed
CompletedNCT02967055
The Effect of Isotretinoin on the Etonogestrel Contraceptive Implant
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 9 (actual)
- Sponsor
- University of Colorado, Denver · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This exploratory study will fill a knowledge gap regarding the pharmacokinetic effects of isotretinoin on the etonogestrel (ENG) contraceptive implant.
Detailed description
The Investigators will enroll only women with an etonogestrel contraceptive implant in place who are initiating isotretinoin therapy through their dermatologist. The Investigators will monitor the subjects serum etonogestrel concentration during isotretinoin therapy but no medications will be provided through this study. No medical devices will be inserted as part of this study either.
Conditions
Timeline
- Start date
- 2017-02-15
- Primary completion
- 2019-04-28
- Completion
- 2019-06-30
- First posted
- 2016-11-17
- Last updated
- 2020-08-11
- Results posted
- 2020-08-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02967055. Inclusion in this directory is not an endorsement.